ARCHIVES

IOM Calls FDA Advisory System Sounds, Suggests Conflict Criteria Changes

This article is from The Cancer Letter archive.

Vol. 19 No. 10 | March 5, 1993

Download PDF Visit The Full Archive

Related Articles

Yervoy-Nivolumab Combination Treatment Shrinks Tumors 80 Percent in Three Months

May 31, 2013

Phase III Vaccine Trial Fails To Improve Overall Survival

October 25, 2013

Vermont Cancer Center’s NCI Core Grant Renewed.

May 11, 2001

DCPC Board Agrees to Commit $62 Million To Trials Of Prostate, Lung, Colorectal Cancer Screening

October 20, 1989

Cancer Centers Could Form Network for Genetics Research, NCI Says

April 12, 1996

Toxicity, Non-Cancer Deaths Increase With Combo Therapy

July 30, 2010